Skip to main content

Table 1 Patient Demographics

From: Malignancy validation in a United States registry of rheumatoid arthritis patients

 

Total CORRONA Population

Total CORRONA Patients Without Malignancy

Total CORRONA Patients With Malignancies

P-Values

(N = 20,839)

(N = 20,438)

(N = 401)**

Age (Mean, SD)

57.7 (13.6)

57.6 (13.9)

65.2 (11.0)

<.0001

Female Gender (N, %)

15,135 (72.8%)

14,883 (73.0%)

252 (62.8%)

<.0001

Race/Ethnicity (N, %)

    

 White

17,292 (84.0%)

16,940 (84.0%)

352 (88.7%)

0.0005

 Hispanic

1,291 (6.3%)

1,275 (6.3%)

16 (4.0%)

 

 Black

1,248 (6.1%)

1,238 (6.1%)

10 (2.5%)

 

 Asian

344 (1.7%)

340 (1.7%)

4 (1.0%)

 

 Other

418 (2.0%)

403 (2.0%)

15 (3.8%)

 

Seropositivity (N, %)

7,400 (67.7%)

7,224 (67.6%)

176 (70.7%)

0.31

RA Disease Duration at Enrollment in CORRONA (mean years, SD)

9.56 (9.8)

9.49 (9.8)

12.56 (11.3)

<.0001

Years of Follow-up After CORRONA Enrollment Until Report of Cancer* (mean, SD)

1.76 (1.6)

1.75 (1.8)

2.26 (1.7)

<.0001

  1. * follow-up time censored at the time of the first report of an incident malignancy.
  2. ** 44 patients had multiple malignancies reported, for a total of 461 reported malignancies.